Skip to content

Prices inUSD

Cart0

Tirzepatide 5 mg Certificate of Analysis

Certificate of Analysis for Tirzepatide 5 mg, report CPT-TIRZEP-815D49
Report number
CPT-TIRZEP-815D49
Batch / lot
L26-01 · CGX-2026
Tested
Sep 27, 2026
Reported
Oct 2, 2026
Laboratory
Canada Peptide Testing (independent)
Method
HPLC-UV purity and content
Reported purity
99.91%
Measured content
5.80 mg (expected 5.00 mg)
Fill accuracy
116.0%
Verify on Canada Peptide Testing Lab PDF View product

How to read this certificate

  • Report number: the lab’s ID for this test. The QR code on the certificate and the Verify button open the same record on canadapeptidetesting.com.
  • HPLC purity: the share of the main compound among everything the chromatography column detected in the sample.
  • Content: the measured amount of compound in the vial, compared with the labelled amount.
  • Tested date: when the lab ran the sample. Each lot is tied to its own report.

About Tirzepatide

A 39-residue synthetic peptide with a C20 fatty-diacid side chain, acting at the GIP and GLP-1 receptors.

Formula C225H348N48O68 · MW 4813 g/mol · CAS 2023788-19-2

Reported results apply to the tested lot. For research use only. Not for use in diagnostic or therapeutic procedures.

0